With the introduction of direct-acting antivirals (DAAs) in Australia in 2016, most people with chronic hepatitis C can be cured of this infection. GPs and suitably qualified nurse practitioners working in all areas of primary care have a key role in identifying, testing and treating their patients with hepatitis C. The previous article in this series discussed how to identify your patients with hepatitis C. This article provides practical advice on assessing a patient after diagnosis in preparation for DAA therapy. This includes determining whether they can be safely treated in general practice or require specialist referral.


hepatitis C, direct-acting antivirals (DAAs), Australia, assessment after diagnosis, treatment, GP or specialist


This article originally published in "Medicine Today".

Permission granted by Medicine Today for use on ResearchOnline@ND.

© Medicine Today 2019 (http://www.medicinetoday.com.au).

Find in your library